Polaris Market Research

Regenerative Medicine Market Size Estimated to Reach $ 79.23 Bn in 2026 at a CAGR of 20.5% - Organogenesis, Vericel Corporation, NuVasive, Medtronic

The global regenerative medicine market is estimated to reach USD 79.23 billion by 2026 from USD 14.76 billion in 2017. The market is anticipated to grow at a CAGR of 20.5% during the forecast period.

 

New York, NY -- (SBWIRE) -- 11/29/2018 -- Regenerative medicine is a field that deals with the repair, replacement or restoration of damaged tissues. The reason behind the emergence of this field is due to the need for reconstruction in children and adults in whom tissue has been injured by diseases, trauma and congenital anomalies. There are various studies being conducted by the researchers for figuring out how to regenerate some of these replacement tissues from the patients' own cells, that will help to reduce the necessity for donor organs and long-term use of immunosuppressant drugs.

For more Professional and Technical Insights Request Sample @
https://www.polarismarketresearch.com/industry-analysis/regenerative-medicine-market/request-for-free-sample

North America Regenerative Medicine Market was estimated to dominate the market growth due to developed healthcare infrastructure, favourable reimbursement schemes, higher healthcare expenditure, and increasing awareness among the population.

Several factors are responsible for the growth of the regenerative medicines market such as, government & private funding are being provided to support the advancement of the regenerative medicine market.

The rising incidences of chronic diseases and genetic disorders and rapid growth in the aging population are also creating a huge demand of regenerative medicines. These researches and studies are getting backed up by increase in healthcare expenditure all across the world. Moreover, there are also increase in corporate partnerships to accelerate development and commercialization of regenerative medicine.

There are also some of the reasons due to which the Regenerative Medicine Market is getting hampered. It has been observed that there are some ethical concerns with the use of embryonic stem cell for R&D and also there is lack of clear regulatory guidelines which creating problems in the growth of the regenerative medicines market. According to the report published by North Carolina Association for Biomedical Research, In 2011, there were 28,5371 organ transplants in the United States, 1,042 of which were done in North Carolina.

Make Enquiry Before Buying the Report @
https://www.polarismarketresearch.com/industry-analysis/regenerative-medicine-market/inquire-before-buying

The report provides an extensive qualitative and quantitative analysis of the market trends and growth prospects of the global regenerative medicine market, 2017-2026. This report also comprises a detailed geographic analysis of the market across North America, Europe, APAC, Latin America, and MEA regions. North America is further segmented into U.S., Canada, and Mexico. European regional analysis section covers Germany, UK, Italy, and France. While the Asia Pacific region is bifurcated into China, India, and Japan. In 2017,

Competitive Landscape and Key Vendors: -
Some of the leading companies profiled in the regenerative medicine market report include Organogenesis Inc., Vericel Corporation, Osiris Therapeutics, Inc., Stryker Corporation, and NuVasive, Inc., Medtronic Plc., Acelity, Cook Biotech Inc., Integra LifeSciences, and C.R. Bard.

These companies launch new products and collaborate with other market leaders to innovate and launch new products to meet the increasing needs and requirements of consumers.

Various major players are performing different activities and they are getting opportunities fulfil the needs of their customers for the rising demand of organ transplantation. Many institutes and organisations are conducting studies and researches for the advancements in the field of regenerative medicines such as, The Wake Forest Institute for Regenerative Medicine, The North Carolina Tissue Engineering and Regenerative Medicine Society and others.

Key Segments:

Therapy:
- Tissue engineering
- Cell Therapy
- Immunotherapy
- Gene Therapy

Products:
- Acellular Products
- Cellular Products

Application:
- Oncology
- Dermatology
- Orthopedic
- Cardiology
- CNS Disease
- Diabetes
- Others

Region :
- North America
o U.S.
o Canada
o Mexico
- Europe
o Germany
o UK
o France
o Italy
o Rest of Europe
- Asia-Pacific
o China
o India
o Japan
o Rest of Asia-Pacific
- Latin America
o Brazil
o Rest of Latin America
- Middle East and Africa

Partial Table of Content of Regenerative Medicine Market: -

1. Overview and Scope
2. Executive Summary
3. Market Insights
4. Industry analysis - Porter's five force
5. Threat of new entrant
6. Degree of competition
7. Market PEST Analysis, 2016
8. Market Value Chain Analysis
9. Industry Trends
10. Competitive Ranking Analysis
11. Company Profiles